Feedback of inter-hospital transfer of patients under high-flow nasal cannula oxygen therapy

• 作者: Emilien Arnaud Sylvain Leclere Martin Petitprez Gilles Vincent Christine Ammirati
• 来源期刊: 世界急诊医学杂志（英文版）
• 年，卷（期）: 2022,（3）
• 所属期刊栏目: Research Letters
• 页码范围: 219-221
• 页数: 3页
• 语种: 中文
• DOI: 10.5847/wjem.j.1920-8642.2022.036

摘要

Severe forms of coronavirus disease 2019(COVID-19)can lead to hypoxemic pneumonia and the need for treatment with high-flow nasal cannula(HFNC)oxygen therapy.[1]This treatment decreases the need for subsequent invasive ventilation in patients with hypoxemic pneumonia.The oxygen flow in the nasal cannula is driven pneumatically or using a turbine.Oxygen and air are mixed(giving the fraction of inspired oxygen[FiO2])and propelled at up to 80 L·mnin-1.The propelled gases must be heated and humidified.HFNC system is not intended for use outside a hospital environment.